Open AccessNaïve Induced Pluripotent Stem Cells Generated From β‐Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9
Author(s) -
Yang Yuanyuan,
Zhang Xiaobai,
Yi Li,
Hou Zhenzhen,
Chen Jiayu,
Kou Xiaochen,
Zhao Yanhong,
Wang Hong,
Sun Xiao-Fang,
Jiang Cizhong,
Wang Yixuan,
Gao Shaorong
Publication year - 2016
Publication title -
stem cells translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.781
H-Index - 71
eISSN - 2157-6580
pISSN - 2157-6564
DOI - 10.5966/sctm.2015-0157
Subject(s) - induced pluripotent stem cell , crispr , biology , embryonic stem cell , genome editing , stem cell , microbiology and biotechnology , kosr , genetics , gene
Conventional primed human embryonic stem cells and induced pluripotent stem cells (iPSCs) exhibit molecular and biological characteristics distinct from pluripotent stem cells in the naïve state. Although naïve pluripotent stem cells show much higher levels of self‐renewal ability and multidifferentiation capacity, it is unknown whether naïve iPSCs can be generated directly from patient somatic cells and will be superior to primed iPSCs. In the present study, we used an established 5i/L/FA system to directly reprogram fibroblasts of a patient with β‐thalassemia into transgene‐free naïve iPSCs with molecular signatures of ground‐state pluripotency. Furthermore, these naïve iPSCs can efficiently produce cross‐species chimeras. Importantly, using the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR‐associated protein 9 nuclease genome editing system, these naïve iPSCs exhibit significantly improved gene‐correction efficiencies compared with the corresponding primed iPSCs. Furthermore, human naïve iPSCs could be directly generated from noninvasively collected urinary cells, which are easily acquired and thus represent an excellent cell resource for further clinical trials. Therefore, our findings demonstrate the feasibility and superiority of using patient‐specific iPSCs in the naïve state for disease modeling, gene editing, and future clinical therapy. Significance In the present study, transgene‐free naïve induced pluripotent stem cells (iPSCs) directly converted from the fibroblasts of a patient with β‐thalassemia in a defined culture system were generated. These naïve iPSCs, which show ground‐state pluripotency, exhibited significantly improved single‐cell cloning ability, recovery capacity, and gene‐targeting efficiency compared with conventional primed iPSCs. These results provide an improved strategy for personalized treatment of genetic diseases such as β‐thalassemia.